source
- Anti-aging biotech NewLimit raises $435M at $3B+ valuationThe Bay Area startup NewLimit has closed one of biotech's largest private financings of 2026 and expects to start human testing next year for its first anti-aging drug candidate. NewLimit said Tues…Endpoints · 1mo ago↗ source
- Eli Lilly issues data sharing ultimatum to 340B hospitalsSelect hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which have until Monday to comply, are urging the government to intervene.BioPharma Dive · 1mo ago↗ source
- STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trialLongevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.